FILANA THERAPEUTICS INC (FLNA) Fundamental Analysis & Valuation

NASDAQ:FLNA • US14817C1071

Current stock price

1.51 USD
+0.06 (+4.14%)
At close:
1.5097 USD
0 (-0.02%)
After Hours:

This FLNA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. FLNA Profitability Analysis

1.1 Basic Checks

  • In the past year FLNA has reported negative net income.
  • In the past year FLNA has reported a negative cash flow from operations.
  • In the past 5 years FLNA always reported negative net income.
  • In the past 5 years FLNA always reported negative operating cash flow.
FLNA Yearly Net Income VS EBIT VS OCF VS FCFFLNA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -50M -100M

1.2 Ratios

  • The Return On Assets of FLNA (-76.86%) is worse than 75.92% of its industry peers.
  • FLNA has a Return On Equity of -122.27%. This is in the lower half of the industry: FLNA underperforms 69.63% of its industry peers.
Industry RankSector Rank
ROA -76.86%
ROE -122.27%
ROIC N/A
ROA(3y)-52.14%
ROA(5y)-40.21%
ROE(3y)-69.9%
ROE(5y)-51.19%
ROIC(3y)N/A
ROIC(5y)N/A
FLNA Yearly ROA, ROE, ROICFLNA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -20 -40 -60 -80 -100

1.3 Margins

  • FLNA does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
FLNA Yearly Profit, Operating, Gross MarginsFLNA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. FLNA Health Analysis

2.1 Basic Checks

  • Compared to 1 year ago, FLNA has more shares outstanding
  • The number of shares outstanding for FLNA has been increased compared to 5 years ago.
  • There is no outstanding debt for FLNA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
FLNA Yearly Shares OutstandingFLNA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M
FLNA Yearly Total Debt VS Total AssetsFLNA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M

2.2 Solvency

  • FLNA has an Altman-Z score of -6.99. This is a bad value and indicates that FLNA is not financially healthy and even has some risk of bankruptcy.
  • The Altman-Z score of FLNA (-6.99) is worse than 69.63% of its industry peers.
  • FLNA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -6.99
ROIC/WACCN/A
WACCN/A
FLNA Yearly LT Debt VS Equity VS FCFFLNA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M -100M 200M

2.3 Liquidity

  • FLNA has a Current Ratio of 2.23. This indicates that FLNA is financially healthy and has no problem in meeting its short term obligations.
  • With a Current ratio value of 2.23, FLNA perfoms like the industry average, outperforming 40.84% of the companies in the same industry.
  • FLNA has a Quick Ratio of 2.23. This indicates that FLNA is financially healthy and has no problem in meeting its short term obligations.
  • FLNA has a Quick ratio (2.23) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 2.23
Quick Ratio 2.23
FLNA Yearly Current Assets VS Current LiabilitesFLNA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. FLNA Growth Analysis

3.1 Past

  • The earnings per share for FLNA have decreased strongly by -314.00% in the last year.
EPS 1Y (TTM)-314%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%54.74%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • Based on estimates for the next years, FLNA will show a very strong growth in Earnings Per Share. The EPS will grow by 158.13% on average per year.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y36.79%
EPS Next 2Y158.13%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
FLNA Yearly Revenue VS EstimatesFLNA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 200K 400K 600K 800K 1M
FLNA Yearly EPS VS EstimatesFLNA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 2 -2 4 6 8

More info and screens

Find the best growth stocksShow best growing peers

1

4. FLNA Valuation Analysis

4.1 Price/Earnings Ratio

  • FLNA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year FLNA is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
FLNA Price Earnings VS Forward Price EarningsFLNA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
FLNA Per share dataFLNA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1

4.3 Compensation for Growth

  • FLNA's earnings are expected to grow with 158.13% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y158.13%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. FLNA Dividend Analysis

5.1 Amount

  • No dividends for FLNA!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

FLNA Fundamentals: All Metrics, Ratios and Statistics

FILANA THERAPEUTICS INC

NASDAQ:FLNA (5/1/2026, 8:00:01 PM)

After market: 1.5097 0 (-0.02%)

1.51

+0.06 (+4.14%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Industry Strength67.7
Industry Growth15.53
Earnings (Last)03-03
Earnings (Next)05-06
Inst Owners28.97%
Inst Owner Change-1.89%
Ins Owners5.78%
Ins Owner ChangeN/A
Market Cap72.93M
Revenue(TTM)N/A
Net Income(TTM)-90.97M
Analysts82.86
Price TargetN/A
Short Float %15.94%
Short Ratio22.4
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)0%
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 0.98
P/tB 0.98
EV/EBITDA N/A
EPS(TTM)-1.88
EYN/A
EPS(NY)-1.24
Fwd EYN/A
FCF(TTM)-0.68
FCFYN/A
OCF(TTM)-0.67
OCFYN/A
SpS0
BVpS1.54
TBVpS1.54
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -76.86%
ROE -122.27%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-52.14%
ROA(5y)-40.21%
ROE(3y)-69.9%
ROE(5y)-51.19%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 62.07%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.23
Quick Ratio 2.23
Altman-Z -6.99
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)32.74%
Cap/Depr(5y)949.19%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-314%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%54.74%
EPS Next Y36.79%
EPS Next 2Y158.13%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y32.56%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y71.95%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y72.42%
OCF growth 3YN/A
OCF growth 5YN/A

FILANA THERAPEUTICS INC / FLNA Fundamental Analysis FAQ

What is the ChartMill fundamental rating of FILANA THERAPEUTICS INC (FLNA) stock?

ChartMill assigns a fundamental rating of 2 / 10 to FLNA.


Can you provide the valuation status for FILANA THERAPEUTICS INC?

ChartMill assigns a valuation rating of 1 / 10 to FILANA THERAPEUTICS INC (FLNA). This can be considered as Overvalued.


How profitable is FILANA THERAPEUTICS INC (FLNA) stock?

FILANA THERAPEUTICS INC (FLNA) has a profitability rating of 0 / 10.


Can you provide the financial health for FLNA stock?

The financial health rating of FILANA THERAPEUTICS INC (FLNA) is 6 / 10.